Research & IP · United Kingdom

Oxitec

Develops and releases genetically engineered self-limiting insects (Friendly Aedes mosquitoes) commercially in Brazil and in EPA-approved US trials.

Headquarters
Abingdon, United Kingdom · Europe
Value chain
Research & IP(Research & design); also Professional & data services
What that means
Invents and licenses: corporate and contract research, IP and technology licensing, with little production of its own.
Founded
2002
Ownership
Private
Website
oxitec.com
Relevance
Moderate at its strongest, in Synthetic Biology & Genetic Engineering

In 1 capability

Each capability the company is listed in, most relevant first: how experts in the field see its global relevance there, why it is listed and the source.

  1. Biotechnology & Health Technologies · Operation · listed #32 of 50

    Develops and releases genetically engineered self-limiting insects (Friendly Aedes mosquitoes) commercially in Brazil and in EPA-approved US trials.

    Relevance: Leading engineered insect developer

    Source · en.wikipedia.org